MENHIBRIX
Live / Registered — Registered and renewed (as of 19 Apr 2017)
What this means for you
Registered since 10 Apr 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §8 & §9 renewal is due by 10 Apr 2027, and its filing window is open now).
Record
- Serial number
- 78587404
- Registration number
- 3226716
- Mark type
- Word mark
- Filed
- 15 Mar 2005
- Published for opposition
- 23 Jan 2007
- Registered
- 10 Apr 2007
- Current term from
- 10 Apr 2017
- Next maintenance filing
- §8 & §9 renewal, due by 10 Apr 2027 (grace period to 10 Oct 2027)
- Attorney of record
- Christopher M. Hanes
Goods and services
- Class 005 — Pharmaceuticals: vaccines for human use
Owner
- GlaxoSmithKline Biologicals S.A., RIXENSART, BE
- GlaxoSmithKline Biologicals S.A., Rixensart, BE
- GlaxoSmithKline Biologicals S.A., Rixensart, BE
Prosecution history
- 10 Apr 2026 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Aug 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Aug 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Aug 2022 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 03 Aug 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 03 Aug 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Aug 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Aug 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 19 Apr 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Apr 2017 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Apr 2017 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Apr 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 23 Feb 2017 — TEAS SECTION 8 & 9 RECEIVED
- 10 Apr 2016 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 08 Jun 2015 — TEAS CHANGE OF CORRESPONDENCE RECEIVED